- Works count
- 665
- Citation count
- 31,300
- H-index
- 75
- i10-index
- 268
Research interests
Publications
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)
The Lancet · 2023 · 10.1016/s0140-6736(22)02546-6
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Annals of the Rheumatic Diseases · 2023 · https://doi.org/10.1136/ard-2023-224762
2021 DORIS definition of remission in SLE: final recommendations from an international task force
Lupus Science & Medicine · 2021 · https://doi.org/10.1136/lupus-2021-000538
2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis
Annals of the Rheumatic Diseases · 2020 · 10.1136/annrheumdis-2020-216924
Low FODMAP Diet: Evidence, Doubts, and Hopes
Nutrients · 2020 · 10.3390/nu12010148
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Annals of the Rheumatic Diseases · 2019 · https://doi.org/10.1136/annrheumdis-2019-215089
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
Annals of the Rheumatic Diseases · 2019 · https://doi.org/10.1136/annrheumdis-2018-214819
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course
Journal of Clinical Medicine · 2019 · 10.3390/jcm8112013
EULAR recommendations for the management of antiphospholipid syndrome in adults
Annals of the Rheumatic Diseases · 2019 · https://doi.org/10.1136/annrheumdis-2019-215213
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
Arthritis & Rheumatology · 2019 · https://doi.org/10.1002/art.40930
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
The Lancet · 2018 · 10.1016/s0140-6736(18)31363-1
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
Annals of the Rheumatic Diseases · 2016 · https://doi.org/10.1136/annrheumdis-2016-209519
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome
Annals of the Rheumatic Diseases · 2016 · https://doi.org/10.1136/annrheumdis-2016-209770
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features
European Respiratory Journal · 2015 · 10.1183/13993003.00150-2015
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
Annals of the Rheumatic Diseases · 2014 · https://doi.org/10.1136/annrheumdis-2013-205139
Systemic lupus erythematosus one disease or many?
Autoimmunity Reviews · 2011 · 10.1016/j.autrev.2011.10.020
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies
Annals of the Rheumatic Diseases · 2009 · 10.1136/ard.2009.117200
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients
Annals of the Rheumatic Diseases · 2008 · 10.1136/ard.2008.093179
Current causes of death in systemic lupus erythematosus in Europe, 2000—2004: relation to disease activity and damage accrual
Lupus · 2007 · 10.1177/0961203307077987
Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy
Annals of the Rheumatic Diseases · 2006 · 10.1136/ard.2006.052191
Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices
Best Practice & Research Clinical Rheumatology · 2005 · 10.1016/j.berh.2005.03.010
Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
Arthritis & Rheumatism · 2002 · https://doi.org/10.1002/art.10187
Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein
The Journal of Experimental Medicine · 2001 · 10.1084/jem.20011124
Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria.
PubMed · 1999
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome.
Annals of the Rheumatic Diseases · 1996 · 10.1136/ard.55.2.116
Current projects
No projects listed.